Cargando…
The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-induced Thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is an adverse reaction to the administration of heparin due to the activation of the platelets by the immunoglobulin G (IgG) antibody-platelet factor 4 (PF4)/heparin immune complex. Since the clinical outcome is uncertain (as it could be associated with signifi...
Autores principales: | Jindal, Vishal, Singh, Aditi, Siddiqui, Ahmad D, Leb, Laszlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318092/ https://www.ncbi.nlm.nih.gov/pubmed/30648066 http://dx.doi.org/10.7759/cureus.3532 |
Ejemplares similares
-
The Role of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia
por: Khalid, Sidra, et al.
Publicado: (2017) -
Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management
por: Patriarcheas, Vasileios, et al.
Publicado: (2020) -
Is COVID-19 an Independent Risk Factor for Heparin-Induced Thrombocytopenia?
por: Madala, Samragnyi, et al.
Publicado: (2021) -
Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia
por: Sahu, Kamal K, et al.
Publicado: (2020) -
Beware of Warfarin-Induced Skin Necrosis in the Setting of Heparin-Induced Thrombocytopenia
por: Dhawan, Natasha
Publicado: (2020)